Pune-based Brinton Pharma to setup R&D centre in UK.

Pune-based drug maker Brinton Pharmaceutical recently said it plans to invest in a global research and development center in the United Kingdom.

The company has proposed to invest 30 million pounds over the next five years to strengthen its product pipelines, create 300 highly skilled jobs in UK and develop innovative products for its global consumers.

The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences.

"The investment helps the company engage in a thriving life sciences ecosystem, supporting their global ambitions to build next generation healthcare products," Brinton said.

The investment proposal was made during UK's Prime Minister Boris Johnson's visit to India on Friday.

"I’m very pleased that Brinton Pharmaceuticals has decided to join the legions of Indian companies investing in the UK, boosting our healthcare sector and driving economic growth,” Johnson said.

“The primary objective is to generate a high-quality portfolio of niche-differentiated products that answer unmet needs. This is a significant step in our long journey to growth and we are quite excited, said Rahulkumar Darda, CMD of Brinton.

ET